Amisha Fnu, Munakomi Sunil
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America
Kathmandu University
Fahr disease is named after Karl Theodor Fahr, a German neurologist who first reported the disorder in 1930. It is a rare neurological condition characterized by abnormal idiopathic calcification of basal ganglia and commonly has an autosomal dominant inheritance. Abnormal calcified deposits (composed of calcium carbonate and phosphate) are not just limited to basal ganglia but also occur in some other locations, such as thalamus, hippocampus, dentate nucleus, cerebral cortex, and cerebellar subcortical white matter. Usually, in the literature, the term Fahr disease and syndrome are used interchangeably, but it has been argued that: For primary basal ganglia calcifications, with no known etiology, the term Fahr disease should be used. For secondary causes of basal ganglia calcifications, with known underlying causes, the term Fahr syndrome should be used. Fahr disease is also termed bilateral strio-pallido-dentate calcinosis or primary familial brain calcification (PFBC) or calcinosis nucleorum.
法尔病以德国神经学家卡尔·西奥多·法尔的名字命名,他于1930年首次报告了这种疾病。它是一种罕见的神经系统疾病,其特征是基底神经节出现异常的特发性钙化,通常具有常染色体显性遗传。异常钙化沉积物(由碳酸钙和磷酸盐组成)不仅限于基底神经节,还出现在其他一些部位,如丘脑、海马体、齿状核、大脑皮层和小脑皮质下白质。通常在文献中,“法尔病”和“法尔综合征”这两个术语可互换使用,但有人认为:对于原发性基底神经节钙化且病因不明的情况,应使用“法尔病”这一术语。对于继发性基底神经节钙化且病因已知的情况,应使用“法尔综合征”这一术语。法尔病也被称为双侧纹状体苍白球齿状核钙化症或原发性家族性脑钙化(PFBC)或核钙化症。